Skip to content
Screener

Fulgent Genetics, Inc. FLGT Intangibles (Net)

Intangibles (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$17.39B-18.7%
Myriad Genetics logo
Myriad GeneticsMYGN
$145.7M-43.4%
Labcorp Holdings logo
Labcorp HoldingsLH
$3.68B+25.7%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.67B-2.0%
NeoGenomics logo
NeoGenomicsNEO
$257.82M-10.6%
Natera, Inc. logo
Natera, Inc.NTRA
$360.2M

Segments

By segment

See full
Laboratory Services$83.3M+21.7%
Therapeutic Development$70.69M+9.5%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherIntangibleAssetsNet.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemMarch 31, 2026December 31, 2025
Marketable securities, long-term328,287369,269
Fixed assets, net116,344112,549
In-process research & development68,49068,490
Other intangible assets, net85,49964,791
Goodwill53,73125,080
Other long-term assets24,97622,856
Total assets$1,156,369$1,213,525
Liabilities and Stockholders’ Equity

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s intangibles (net)?
Fulgent Genetics, Inc. (FLGT) reported intangibles (net) of $85.5M in Q1 2026.
How has Fulgent Genetics, Inc.'s intangibles (net) changed year-over-year?
Fulgent Genetics, Inc.'s intangibles (net) decreased by 35.7% year-over-year, from $133.01M to $85.5M.
What is the long-term trend for Fulgent Genetics, Inc.'s intangibles (net)?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s intangibles (net) has grown at a 15.9% compound annual growth rate (CAGR), from $35.91M to $64.79M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Fulgent Genetics, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude